Results 51 to 60 of about 15,909 (188)
Immunotherapies can lead to an immune compromised state that can allow for opportunistic pathogens such as Rhodococcus to flourish. The vast majority of Rhodococcus infections occur in immunocompromised hosts.
Rosalie M. Sterner +4 more
doaj +1 more source
ABSTRACT The role of the cell envelope‐associated Rv0132c/FGD2 from Mycobacterium tuberculosis has long been a subject of debate. Importantly, FGD2 is found only in pathogenic mycobacteria, making it a potential drug target. While some suggest it functions as a glucose‐6‐phosphate dehydrogenase, others propose it acts instead as an F420‐dependent ...
Adewale V. Aderemi +12 more
wiley +1 more source
<zakljucak> Humana R. equi infekcija jos uvek je retko oboljenje koje se javlja uglavnom kod osoba sa teskim stepenom imunodeficijencije. Najcesce se ispoljava u vidu subakutne bakterijske pneumonije sa kavitacijama, a karakterise se cestim recidivima, bakterijemijama i visokom stopom mortaliteta. Terapija R.
openaire +3 more sources
This show the biodegradation of spent lubricating oil by Bacillus sp. and a marine bacterial consortium. The consortium showed higher growth, biosurfactant production and oil removal efficiency than the isolated strain, highlighting its potential for bioremediation ABSTRACT Spent automotive lubricating oil contains complex hydrocarbons and heavy metals,
Letícia Carvalho Eustaquio Costa +5 more
wiley +1 more source
Exploring the Diversity and Specificity of Secondary Biosynthetic Potential in Rhodococcus
The actinomycete genus Rhodococcus is known for its diverse biosynthetic enzymes, with potential in pollutant degradation, chemical biocatalysis, and natural product exploration.
Gang-Ao Hu +7 more
doaj +1 more source
Recombinant Protein Expression in Rhodococcus species
Abstract Producing recombinant bacterial proteins is essential for elucidating their structure and function, making efficient overexpression systems a key requirement. Escherichia coli is widely used for this purpose, particularly for bacterial proteins, but certain targets remain challenging to express or obtain as soluble protein.
Michael Akintubosun, Melanie A. Higgins
wiley +1 more source
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality worldwide with challenging clinical treatment. Accumulating evidence demonstrates that gut dysbiosis promotes HCC progression, and intratumoral bacteria play an ...
Qisha Liu +7 more
doaj +1 more source
Rhodococcus equi infection: A diverse spectrum of disease
Rhodococcus equi is a gram positive bacterium most commonly presenting clinically as pneumonia, however can disseminate to cause disease in virtually any human tissue.
Adam Stewart +4 more
doaj +1 more source
Intratumoral Microbiota in Tumor: Current Understandings and Future Perspectives
Intratumoral bacteria are emerging as active regulators of cancer evolution rather than bystanders. This review outlines how tumor‐resident microbes drive tumor initiation and growth by inducing genomic instability, epigenetic reprogramming, oncogenic signaling, and chronic inflammation, while promoting metastatic spread via invasion, angiogenesis ...
Jiawei Chen +6 more
wiley +1 more source
HaloTag Fusion Enables Dynamic Analysis of Prion Protein Biosynthesis, Turnover, and Misfolding
Prion protein (PrP) misfolding underlies fatal neurodegenerative diseases. We developed a HaloTag‐based PrP fusion enabling spatiotemporal labeling of distinct PrP populations in living cells. This system recapitulates native PrP biology, reveals early misfolding events in disease‐associated mutants, and allows mechanistic interrogation of PrP‐lowering
Antonio Masone +2 more
wiley +1 more source

